Moore Kuehn, PLLC Encourages Investors to Global Compensation
NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a Wall Street-based securities law firm, is investigating whether certain officers and directors of
NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a Wall Street-based securities law firm, is investigating whether certain officers and directors of
NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a Wall Street-based securities law firm, is investigating whether certain officers and directors of
NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a Wall Street-based securities law firm, is investigating whether certain officers and directors of
SAN DIEGO, Sept. 22, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistula, LLP announces that a class action lawsuit has been filed on
SAN DIEGO, Sept. 22, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistula, LLP announces that a class action lawsuit has been filed on
Reuters Nio, CATL’s third-largest customer after Tesla, is reducing its reliance on the battery giant to achieve diversification XPeng Inc XPEV has diversified its battery
SAN FRANCISCO, 22/09/2022 (GLOBE NEWSWIRE) — Hagens Berman calls on Fulgent Genetics, Inc. (NASDAQ:FALG) to sell $1.5 billion. FLGT Investors who have suffered significant losses
SAN FRANCISCO, 22/09/2022 (GLOBE NEWSWIRE) — Hagens Berman calls on Fulgent Genetics, Inc. (NASDAQ:FALG) to sell $1.5 billion. (NASDAQ:FLGT) Investors who have suffered significant losses
VANCOUVER, British Columbia and LISBON, Portugal, September 22, 2022 (GLOBE NEWSWIRE) — TUGA Innovations, Inc. SADNESS DQ TUGAF (“TUGA Innovations” or the “Company”), which develops
Patent filing based on research at Hebrew University is latest result of ongoing collaboration with SciSparc Ltd. VANCOUVER, Sept. 22, 2022 (GLOBE NEWSWIRE) — Clearmind
Patent filing based on research at Hebrew University is latest result of ongoing collaboration with SciSparc Ltd. VANCOUVER, Sept. 22, 2022 (GLOBE NEWSWIRE) — Clearmind
TEL AVIV, Israel, September 22, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. SPRC (“Company” or “SciSparc”), a clinical-stage specialty pharmaceutical company focused on developing therapies to
NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a Wall Street-based securities law firm, is investigating whether certain officers and directors of
NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a Wall Street-based securities law firm, is investigating whether certain officers and directors of
NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a Wall Street-based securities law firm, is investigating whether certain officers and directors of
SAN DIEGO, Sept. 22, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistula, LLP announces that a class action lawsuit has been filed on
SAN DIEGO, Sept. 22, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistula, LLP announces that a class action lawsuit has been filed on
Reuters Nio, CATL’s third-largest customer after Tesla, is reducing its reliance on the battery giant to achieve diversification XPeng Inc XPEV has diversified its battery
SAN FRANCISCO, 22/09/2022 (GLOBE NEWSWIRE) — Hagens Berman calls on Fulgent Genetics, Inc. (NASDAQ:FALG) to sell $1.5 billion. FLGT Investors who have suffered significant losses
SAN FRANCISCO, 22/09/2022 (GLOBE NEWSWIRE) — Hagens Berman calls on Fulgent Genetics, Inc. (NASDAQ:FALG) to sell $1.5 billion. (NASDAQ:FLGT) Investors who have suffered significant losses
VANCOUVER, British Columbia and LISBON, Portugal, September 22, 2022 (GLOBE NEWSWIRE) — TUGA Innovations, Inc. SADNESS DQ TUGAF (“TUGA Innovations” or the “Company”), which develops
Patent filing based on research at Hebrew University is latest result of ongoing collaboration with SciSparc Ltd. VANCOUVER, Sept. 22, 2022 (GLOBE NEWSWIRE) — Clearmind
Patent filing based on research at Hebrew University is latest result of ongoing collaboration with SciSparc Ltd. VANCOUVER, Sept. 22, 2022 (GLOBE NEWSWIRE) — Clearmind
TEL AVIV, Israel, September 22, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. SPRC (“Company” or “SciSparc”), a clinical-stage specialty pharmaceutical company focused on developing therapies to